POLYMORPHISMS IN PGE2 PATHWAY GENES AS RISK MARKERS FOR COLORECTAL CANCER DEVELOPMENT: AN OPPORTUNITY FOR TARGETED SCREENING AND/OR CHEMOPREVENTION?

(1) PORTUGUESE INSTITUTE OF ONCOLOGY - PORTO



This item was part of the OTHER LOWER GI DISORDERS II session at 20th United European Gastroenterology Week

This item can be cited as: Gut 2012; 61 (Suppl 3) A295